The 7 analysts offering 12-month price forecasts for Emergent BioSolutions Inc have a median target of 37.00, with a high estimate of 65.00 and a low estimate of 29.00. The median estimate represents a +76.19% increase from the last price of 21.00.
The current consensus among 8 polled investment analysts is to Hold stock in Emergent BioSolutions Inc. This rating has held steady since April, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.06
Reporting Date Nov 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.